MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/cancers13225674

Медицинская библиотека · Cancers · 2021

Relationship between Serum Bortezomib Concentration and Emergence of Diarrhea in Patients with Multiple Myeloma and/or AL Amyloidosis.

Fujimoto Yuki, Ueno Shikiko, Oda Kazutaka, Gunda Nao, Shimomura Yumi, Nishimura Yuka, Yamaguchi Ayami, Kuwano Akari, Ito Yuki, Baba Yusuke, Nishigaki Aina, Michiwaki Natsumi, Uchino Shota, Kurogi Kayo, Kawano Yawara, Matsuoka Masao, Saito Hideyuki, Okuno Yutaka, Jono Hirofumi

СтатьяПеревод пока не подготовлен

Аннотация

(1)

Background

multiple myeloma patients have benefited from bortezomib therapy, though it has often been discontinued owing to diarrhea. The objective of this study was to verify serum bortezomib concentration in the emergence of diarrhea. (2)

Methods

this prospective, observational case-control, and monocentric study was performed with an approval by the Ethics Committee of Kumamoto University Hospital in 2015 (No. 1121) from February 2015 to April 2017. (3)

Results

twenty-four patients with bortezomib therapy were recruited; eight patients (33.3%) developed diarrhea at day 3 as median. Median measured trough bortezomib concentration at 24 h after first or second dose for patients with or without diarrhea was 0.87 or 0.48 ng/mL, respectively (p = 0.04, Wilcoxon signed rank test). Receiver operation characteristic (ROC) analysis produced the cut-off concentration of 0.857 ng/mL (area under the ROC curve of 0.797, sensitivity of 0.625, specificity of 0.875). The survival curves between patients with and without diarrhea were similar (p = 0.667); those between patients with higher and lower concentration than median value (0.61 ng/mL) were also similar (p = 0.940). (4)

Conclusions

this study indicated the possible involvement of serum bortezomib concentration in the emergence of diarrhea in bortezomib therapy in patients with multiple myeloma.

Для цитирования: Fujimoto Yuki, Ueno Shikiko, Oda Kazutaka, Gunda Nao, Shimomura Yumi, Nishimura Yuka, Yamaguchi Ayami, Kuwano Akari, Ito Yuki, Baba Yusuke, Nishigaki Aina, Michiwaki Natsumi, Uchino Shota, Kurogi Kayo, Kawano Yawara, Matsuoka Masao, Saito Hideyuki, Okuno Yutaka, Jono Hirofumi. Relationship between Serum Bortezomib Concentration and Emergence of Diarrhea in Patients with Multiple Myeloma and/or AL Amyloidosis.. Cancers. 2021. DOI: 10.3390/cancers13225674.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.